Recordati Industria Chimica e Farmaceutica S.p.A. (OTCMKTS:RCDTF - Get Free Report) was up 33.6% on Friday . The company traded as high as $65.44 and last traded at $65.44. Approximately 300 shares traded hands during mid-day trading, a decline of 65% from the average daily volume of 850 shares. The stock had previously closed at $49.00.
Recordati Industria Chimica e Farmaceutica Trading Up 33.6%
The firm has a market capitalization of $13.50 billion, a P/E ratio of 32.72 and a beta of 0.26. The company has a 50-day moving average of $54.27 and a 200-day moving average of $54.53.
About Recordati Industria Chimica e Farmaceutica
(
Get Free Report)
Recordati Industria Chimica e Farmaceutica S.p.A., together with its subsidiaries, engages in the research, development, manufacture, and marketing of pharmaceuticals worldwide. The company operates through Specialty and Primary Care and Rare Diseases segments. Its product pipeline includes REC 0559 which is in Phase II for the treatment of Neurotrophic Keratitis; REC 0545 for acute decompensation in maple syrup urine diseases; ISTURISA for endogenous Cushing's syndrome; and CYSTADROPS, an corneal cystine deposits in patients with cystinosis.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Recordati Industria Chimica e Farmaceutica, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Recordati Industria Chimica e Farmaceutica wasn't on the list.
While Recordati Industria Chimica e Farmaceutica currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
